US17166A1016
US17166A1016
Cibus, Inc.
Loading chart...
Company Profile
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Latest News

GlobeNewswire • 09/28/2026
Cibus and Crystal Crop Protection Team Up to Improve India’s Mustard Crop

Motley Fool • 08/20/2026
Cibus (CBUS) Q2 2026 Earnings Call Transcript

Moby • 08/14/2026
Cibus, Inc. Q2 2026 Earnings Call Summary
GuruFocus.com • 08/14/2026
Cibus Inc (CBUS) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trait Pipeline Model ...
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
Company Profile
5
MetricsCountry
Region
Sector
Industry
Website
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
5Y Volatility
115.6% p.a.
Max Drawdown (5Y)
-99.4%
Sharpe Ratio (5Y)
-0.54
Beta Factor
1.57
Size Class
Micro Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 1934%.
High market risk: Beta of 1.57 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (115.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -99.9% in the extended horizon.